Robin Germany to Humans
This is a "connection" page, showing publications Robin Germany has written about Humans.
Connection Strength
0.322
-
Sleep and breathing disorders in heart failure. Handb Clin Neurol. 2022; 189:295-307.
Score: 0.043
-
Non-Mask-based Therapies for Central Sleep Apnea in Patients with Heart Failure. Sleep Med Clin. 2017 Jun; 12(2):255-264.
Score: 0.031
-
Sleep-disordered breathing and cardiovascular disease. Indian Heart J. 2016 Apr; 68 Suppl 1:S69-76.
Score: 0.028
-
A novel therapeutic approach for the treatment of central sleep apnea: The remede® system. Cardiovasc Revasc Med. 2014 Jun; 15(4):235-9.
Score: 0.025
-
Controversies in cardiac resynchronization therapy: do sex differences in response exist? Curr Heart Fail Rep. 2011 Mar; 8(1):59-64.
Score: 0.020
-
The use of device-based diagnostics to manage patients with heart failure. Congest Heart Fail. 2008 Sep-Oct; 14(5 Suppl 2):19-24.
Score: 0.017
-
The evaluation and monitoring of volume status in congestive heart failure. Congest Heart Fail. 2008 May-Jun; 14(3):135-40.
Score: 0.017
-
Use of device diagnostics in the outpatient management of heart failure. Am J Cardiol. 2007 May 21; 99(10A):11G-6G.
Score: 0.015
-
Candesartan in heart failure. Clin Interv Aging. 2006; 1(4):357-66.
Score: 0.014
-
The Utility of Home Sleep Apnea Testing in the Advanced Heart Failure Populations. Am J Cardiol. 2023 03 15; 191:8-13.
Score: 0.011
-
Design of the remede System Therapy (reST) study: A prospective non-randomized post-market study collecting clinical data on safety and effectiveness of the remede system for the treatment of central sleep apnea. Sleep Med. 2022 Dec; 100:238-243.
Score: 0.011
-
Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea. J Cardiovasc Transl Res. 2021 04; 14(2):377-385.
Score: 0.010
-
Transvenous phrenic nerve stimulation for central sleep apnea is safe and effective in patients with concomitant cardiac devices. Heart Rhythm. 2020 12; 17(12):2029-2036.
Score: 0.010
-
Meta-Analysis Comparing Outcomes of Therapies for Patients With Central Sleep Apnea and Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2020 07 15; 127:73-83.
Score: 0.009
-
Novel phrenic nerve stimulator treats Cheyne-Stokes respiration: polysomnographic insights. J Clin Sleep Med. 2020 05 15; 16(5):817-820.
Score: 0.009
-
Phrenic nerve stimulation in patients with central sleep apnea: a single-center experience from pilot and pivotal trials evaluating the remede System. Kardiol Pol. 2019 May 24; 77(5):553-560.
Score: 0.009
-
In patients with heart failure the burden of central sleep apnea increases in the late sleep hours. Sleep. 2019 01 01; 42(1).
Score: 0.009
-
Novel Therapies for the Treatment of Central Sleep Apnea. Sleep Med Clin. 2016 Jun; 11(2):227-39.
Score: 0.007
-
Sleep disordered breathing in patients with heart failure. Cardiol J. 2013; 20(4):345-55.
Score: 0.006
-
Uncovering interim clinical events at the time of clinical encounter by reviewing intrathoracic impedance threshold crossings. J Card Fail. 2011 Nov; 17(11):893-8.
Score: 0.005
-
Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure. Eur Heart J. 2012 Apr; 33(7):889-94.
Score: 0.005
-
Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study. Clin Ther. 2010 Mar; 32(3):506-14.
Score: 0.005
-
Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. 2009 Aug; 15(6):475-81.
Score: 0.004
-
Apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins in obese girls. Clin Chem. 2003 Feb; 49(2):303-6.
Score: 0.003